News
BNR
9.01
-10.79%
-1.09
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
Weekly Report: what happened at BNR last week (0518-0522)?
Weekly Report · 4d ago
Jefferies upgrades Burning Rock Biotech (BNR) to a Hold
TipRanks · 5d ago
Weekly Report: what happened at BNR last week (0511-0515)?
Weekly Report · 05/18 10:17
Weekly Report: what happened at BNR last week (0504-0508)?
Weekly Report · 05/11 10:15
Weekly Report: what happened at BNR last week (0427-0501)?
Weekly Report · 05/04 10:12
Burning Rock FY25 net loss narrows 84% to RMB 55.3 million; revenue rises 4.6% to RMB 539.6 million
PUBT · 04/28 10:32
Burning Rock Publishes 2025 Annual Report on Form 20-F
Barchart · 04/28 05:45
Weekly Report: what happened at BNR last week (0420-0424)?
Weekly Report · 04/27 10:15
Weekly Report: what happened at BNR last week (0413-0417)?
Weekly Report · 04/20 10:11
Aurelion appoints Yuki Xu acting chief accounting officer, replacing Hattie He
PUBT · 04/13 20:17
Weekly Report: what happened at BNR last week (0406-0410)?
Weekly Report · 04/13 10:15
Weekly Report: what happened at BNR last week (0330-0403)?
Weekly Report · 04/06 10:15
Insider Makes Bold Multi-Million Dollar Bet on Burning Rock Biotech
TipRanks · 04/03 02:05
Burning Rock director Han Yusheng buys USD 5.5 million in common shares
Reuters · 04/02 11:18
Burning Rock Biotech founder and CEO purchases company ADSs
TipRanks · 04/02 10:44
Burning Rock founder Han buys ADSs worth US$1.4 million
Reuters · 04/02 10:26
Burning Rock Announces Founder’s Purchase of Its ADSs
Barchart · 04/02 05:25
Weekly Report: what happened at BNR last week (0323-0327)?
Weekly Report · 03/30 10:15
Weekly Report: what happened at BNR last week (0316-0320)?
Weekly Report · 03/23 10:12
More
Webull provides a variety of real-time BNR stock news. You can receive the latest news about Burning Rock Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About BNR
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.